This text is a result of machine translation.
The recovery of overseas business offset the recurrence of domestic epidemic, and the net revenue of Ctrip group in 2022q1 was flat on a year-on-year basis
The spot quotation of RMB against the US dollar rose by more than 100 points in the afternoon.
The opening of tourism sector raised the limit of Lijiang shares
Guizhou reissued 155million yuan worth of cultural tourism consumption coupons on the 26th
2022 China AI Health 30 Report
Huada Technology: Jiangsu Hengyi, a holding subsidiary, participated in the relevant technology research and development of Ningde times ctp3.0 Kirin battery
Russian finance minister says West creates artificial obstacles for Russia to repay public debt
The maximum payment limit of employee medical insurance in Shanghai in 2022 was raised to 590000 yuan
Sanlian board Shenma power: the company's gross profit margin declined to a certain extent in the first quarter
CRO ClinChoice Raises USD 150 Mn in Series E Round
2015 is the inflection point for the development of China's innovative drug industry and CRO (clinical research organization). On July 22nd, 2015, after CDE (Center For Drug Evaluation) released the announcement on self-examination and verification of drug clinical trial data, the supervision of Chinese clinical trials moved towards standardization. The investment and financing of innovative drugs in China continued to increase, laying the foundation for the growth of CRO.
Jul 05, 2022 08:17 PM
The private placement market is full of chaos, and the regulators' sword is intended to support the good and limit the bad
Cro plate fell, and Wuxi apptec fell nearly 10%
The trading limit of AVIC electronics and AVIC electromechanical resumed
Trip.com Q1 2021 Financial Results: Net Profit Increased by 80%
On May 19, China's travel service provider, Trip.com filed unaudited financial results for the first quarter ending March 31, 2021, which is the company's first financial report after the secondary listing on the Hong Kong Stock Exchange.
May 19, 2021 12:44 PM
The whole vehicle sector led the decline in opening trading, and Dongfeng Motor was close to the limit
Wei Lai, Li Bin: it is expected that the gross profit margin will rebound from the third quarter
The port sector continued to strengthen and Guangzhou port rose by the daily limit
Cross provincial travel "fuse" accurate to "county" Ctrip cross provincial travel product search volume increased by more than 60%
20 Chinese Companies to Watch in Q1 2023 – Technology
Mar 27, 2023 05:43 PM